Fluorescence Guided Resection of Brain Tumors
NCT00870779
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
105
Enrollment
OTHER
Sponsor class
Conditions
Brain Tumors
Interventions
DRUG:
5-aminolevulinic acid
Sponsor
David W. Roberts
Collaborators
[object Object]